Siemens Announces Early Termination of Hart-Scott-Rodino Period

Siemens Medical Solutions, a wholly owned subsidiary of Siemens AG, and CTI Molecular Imaging announced that the antitrust waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the previously announced tender offer to acquire all the issued and outstanding shares of CTI Molecular Imaging has been terminated. The Federal Trade Commission (FTC) has informed Siemens that the request for early termination of the 15-calendar day waiting period prescribed by the HSR Act was granted.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=499741XSL_NEWSML_TO_NEWSML_WEB.xml)